Atossa Therapeutics, Inc.ATOSNASDAQ
LOADING
|||
Revenue CAGR (5Y)
—
Margin Trend
stable
Free Cash Flow
($0.0B)
Profitability
Unprofitable
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -0 | -0↑50.6% | -0↑65.2% | -0↓187.5% | -0↑26.1% |
| Operating Income | -15 | -21↓40.5% | -28↓34.9% | -31↓13.3% | -28↑12.0% |
| Net Income | -18 | -21↓15.6% | -27↓30.8% | -30↓11.6% | -26↑15.3% |
| EBITDA | -15 | -20↓40.8% | -28↓35.1% | -31↓13.3% | -28↑12.0% |
| EPS Diluted | -29.55 | -2.70↑90.9% | -3.15↓16.7% | -3.60↓14.3% | -3.00↑16.7% |
1 / 2
Values in millions except EPS · Ratios shown as percentages